Mansoor Raza Mirza - Concepedia

Author

Mansoor Raza Mirza

Also Known As

Hannelore Denys, K. Shen, Line Bjørge, M Mirza, M Raza Mirza, M. MIRZA, M. Mirza, M. R. Mirza, M. Raza Mirza, M.R. Mirza

475

Publications

20.4K

Citations

H-Index

Concepts

All Affiliations

Rigshospitalet Copenhagen University Hospital Nordic Society of Gynecologic Oncology Spanish Ovarian Cancer Research Group European Institute of Oncology

About

Mansoor Raza Mirza is an author at Rigshospitalet specializing in medicine, oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	64	9.7K
2	Health Sciences	11	13	853
3	Cell Biology	2	2	127
4	Public Health	1	1	36
5	Cellular Therapies	1	1	116

Mansoor Raza Mirza

121

Publications

16.4K

Citations

H-Index

Page 1

	Year	Citations
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma Nicole Concin, Xavier Matías‐Guiu, Ignace Vergote, International Journal of Gynecological Cancer Endocrine-related CancerMedicineCancer ManagementGynecologyEsgo/estro/esp Guidelines	2020	1.8K
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial Éric Pujade-Lauraine, Felix Hilpert, B. Weber, Journal of Clinical Oncology	2014	1.6K
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up Nicoletta Colombo, Carien L. Creutzberg, Frédéric Amant, Annals of Oncology Gynecological SurgeryMedicineGynecologyEndometrial CancerOncology	2015	1.4K
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease Nicoletta Colombo, Cristiana Sessa, Andreas du Bois, Annals of Oncology Borderline TumoursTumoral PathologyMedicinePathologyGynecology	2019	1.1K
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial Amit M. Oza, Adrian Cook, Jacobus Pfisterer, The Lancet Oncology	2015	845
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer Nicoletta Colombo, Carien L. Creutzberg, Frédéric Amant, International Journal of Gynecological Cancer	2015	745
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer Mansoor Raza Mirza, Dana M. Chase, Brian M. Slomovitz, New England Journal of Medicine	2023	718
Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Ana Oaknin, Tjalling Bosse, Carien L. Creutzberg, Annals of Oncology	2022	573
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study Robert L. Coleman, Domenica Lorusso, Christine Gennigens, The Lancet Oncology Tisotumab VedotinCervical CancerMetastatic Cervical CancerMedicineClinical Trials	2021	367
Cancer of the corpus uteri Frédéric Amant, Mansoor Raza Mirza, Martin Koskas, International Journal of Gynecology & Obstetrics	2018	345

Page 1